Neil Gallagher, MD, PHD

Dr. Neil Gallagher, M.D., Ph.D. has served as a member of our Board of Directors since May 2025. He has over 20 years of experience at pharmaceutical and biopharmaceutical organizations leading drug development programs across several therapeutic areas, including oncology.

Neil most recently served as the president, and head of research and development at Syndax Pharmaceuticals. Prior to that, he held clinical development roles at AbbVie, including serving as the chief medical officer and as vice president, head of development. Neil also held development positions at Amgen, spent a decade at Novartis Oncology, and earlier in his career held roles at AstraZeneca and Astex Therapeutics. He also serves on the boards of directors of several companies, reflecting his broad industry and leadership experience.

Neil completed his fellowship in gynecological oncology at the Institute for Cancer Studies, University of Birmingham, UK, and received his medical degree from Trinity College, Dublin.